220 related articles for article (PubMed ID: 24379443)
1. PIASy-mediated sumoylation of SREBP1c regulates hepatic lipid metabolism upon fasting signaling.
Lee GY; Jang H; Lee JH; Huh JY; Choi S; Chung J; Kim JB
Mol Cell Biol; 2014 Mar; 34(6):926-38. PubMed ID: 24379443
[TBL] [Abstract][Full Text] [Related]
2. Ring finger protein20 regulates hepatic lipid metabolism through protein kinase A-dependent sterol regulatory element binding protein1c degradation.
Lee JH; Lee GY; Jang H; Choe SS; Koo SH; Kim JB
Hepatology; 2014 Sep; 60(3):844-57. PubMed ID: 24425205
[TBL] [Abstract][Full Text] [Related]
3. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors.
Zhang Y; Gan Z; Huang P; Zhou L; Mao T; Shao M; Jiang X; Chen Y; Ying H; Cao M; Li J; Li J; Zhang WJ; Yang L; Liu Y
J Biol Chem; 2012 Nov; 287(45):37973-85. PubMed ID: 22969086
[TBL] [Abstract][Full Text] [Related]
4. PIASy inhibits virus-induced and interferon-stimulated transcription through distinct mechanisms.
Kubota T; Matsuoka M; Xu S; Otsuki N; Takeda M; Kato A; Ozato K
J Biol Chem; 2011 Mar; 286(10):8165-8175. PubMed ID: 21199872
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
6. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger.
Deng Z; Wan M; Sui G
Mol Cell Biol; 2007 May; 27(10):3780-92. PubMed ID: 17353273
[TBL] [Abstract][Full Text] [Related]
7. PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia.
Kang X; Li J; Zou Y; Yi J; Zhang H; Cao M; Yeh ET; Cheng J
Oncogene; 2010 Oct; 29(41):5568-78. PubMed ID: 20661221
[TBL] [Abstract][Full Text] [Related]
8. Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expression of their target genes, low density lipoprotein uptake, and lipid synthesis.
Arito M; Horiba T; Hachimura S; Inoue J; Sato R
J Biol Chem; 2008 May; 283(22):15224-31. PubMed ID: 18403372
[TBL] [Abstract][Full Text] [Related]
9. FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells.
Chen A; Chen X; Cheng S; Shu L; Yan M; Yao L; Wang B; Huang S; Zhou L; Yang Z; Liu G
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):538-548. PubMed ID: 29486327
[TBL] [Abstract][Full Text] [Related]
10. PIASy-mediated repression of the Ets-1 is independent of its sumoylation.
Nishida T; Terashima M; Fukami K
Biochem Biophys Res Commun; 2006 Jul; 345(4):1536-46. PubMed ID: 16729975
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
[TBL] [Abstract][Full Text] [Related]
12. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Ihara M; Yamamoto H; Kikuchi A
Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
[TBL] [Abstract][Full Text] [Related]
13. CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis.
Zhang Z; Wen H; Peng B; Weng J; Zeng F
FASEB J; 2021 Apr; 35(4):e21230. PubMed ID: 33769609
[TBL] [Abstract][Full Text] [Related]
14. SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-β Responses.
Liu S; Long J; Yuan B; Zheng M; Xiao M; Xu J; Lin X; Feng XH
J Biol Chem; 2016 Nov; 291(47):24418-24430. PubMed ID: 27703003
[TBL] [Abstract][Full Text] [Related]
15. Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK.
Li X; Vadrevu S; Dunlop A; Day J; Advant N; Troeger J; Klussmann E; Jaffrey E; Hay RT; Adams DR; Houslay MD; Baillie GS
Biochem J; 2010 Apr; 428(1):55-65. PubMed ID: 20196770
[TBL] [Abstract][Full Text] [Related]
16. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.
Martin N; Schwamborn K; Urlaub H; Gan B; Guan JL; Dejean A
Mol Cell Biol; 2008 Apr; 28(8):2771-81. PubMed ID: 18285457
[TBL] [Abstract][Full Text] [Related]
17. PIASxα ligase enhances SUMO1 modification of PTEN protein as a SUMO E3 ligase.
Wang W; Chen Y; Wang S; Hu N; Cao Z; Wang W; Tong T; Zhang X
J Biol Chem; 2014 Feb; 289(6):3217-30. PubMed ID: 24344134
[TBL] [Abstract][Full Text] [Related]
18. SYT-SSX1 (synovial sarcoma translocated) regulates PIASy ligase activity to cause overexpression of NCOA3 protein.
Sun Y; Perera J; Rubin BP; Huang J
J Biol Chem; 2011 May; 286(21):18623-32. PubMed ID: 21454665
[TBL] [Abstract][Full Text] [Related]
19. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.
Bischof O; Schwamborn K; Martin N; Werner A; Sustmann C; Grosschedl R; Dejean A
Mol Cell; 2006 Jun; 22(6):783-794. PubMed ID: 16793547
[TBL] [Abstract][Full Text] [Related]
20. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock.
Martin N; Schwamborn K; Schreiber V; Werner A; Guillier C; Zhang XD; Bischof O; Seeler JS; Dejean A
EMBO J; 2009 Nov; 28(22):3534-48. PubMed ID: 19779455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]